COSCIENS Biopharma Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
COSCIENS Biopharma Inc. made a loss over the last year.
Compared with Healthcare companies in Canada.
P/E ratio
LossCOSCIENS Biopharma Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.41The share price is 0.41 times COSCIENS Biopharma Inc.'s book value per share, lower than 92% of Healthcare companies in Canada.
Market cap
C$8 MThe total market value of all of COSCIENS Biopharma Inc.'s shares at today's price (share price × number of shares), smaller than 73% of Healthcare companies in Canada. PosiCap size class: Nano Cap.
Return on equity (ROE)
-52.8%COSCIENS Biopharma Inc. lost 52.8% of its shareholders' money over the last year, lower than 66% of Healthcare companies in Canada.
Dividend yield
NoneCOSCIENS Biopharma Inc. does not currently pay a dividend.
Questions
What is COSCIENS Biopharma Inc.'s return on equity?
COSCIENS Biopharma Inc. lost 52.8% of its shareholders' money over the last year, lower than 66% of Healthcare companies in Canada.
Does COSCIENS Biopharma Inc. pay a dividend?
No. COSCIENS Biopharma Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.